Home

Dispuesto pálido Expulsar a 6 diazo 5 oxo l norleucine Deflector oportunidad Desaparecido

File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons
File:6-diazo-5-oxo-L-norleucine.png - Wikimedia Commons

6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology
6-Diazo-5-oxo-L-norleucine | CAS 157-03-9 | SCBT - Santa Cruz Biotechnology

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect
Model studies towards prodrugs of the glutamine antagonist 6-diazo-5-oxo-l- norleucine (DON) containing a diazo precursor - ScienceDirect

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich

Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... |  Download Scientific Diagram
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram

6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics
6 Diazo 5 Oxonorleucine - an overview | ScienceDirect Topics

Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... |  Download Scientific Diagram
Chemical structure of 6-diazo-5-oxo-l-norleucine (DON) and the prodrug... | Download Scientific Diagram

Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF  Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of  Medicinal Chemistry
Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma | Journal of Medicinal Chemistry

6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman  Chemical
6-diazo-5-oxo-L-nor-Leucine (DON, NSC 7365, CAS Number: 157-03-9) | Cayman Chemical

WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine  (don) and other glutamine antagonists - Google Patents
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents

Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant  pancreatic cancer | Scientific Reports
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer | Scientific Reports

Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using  Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs | Journal of Medicinal Chemistry

6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich
6-Diazo-5-oxo-L-norleucine ≥98.0% (UV) | Sigma-Aldrich

Glutamine deficiency induces DNA alkylation damage and sensitizes cancer  cells to alkylating agents through inhibition of ALKBH enzymes | PLOS  Biology
Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes | PLOS Biology

6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E
6-Diazo-5-oxo-L-norleucine-cancer research-TOKU-E

6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem
6-diazo-5-oxo-L-norleucine | C6H9N3O3 - PubChem

6-Diazo-5-oxo-L-norleucine - Wikipedia
6-Diazo-5-oxo-L-norleucine - Wikipedia

The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine  induces a quiescent energetic phenotype and limits substrate flexibility in  colon cancer cells
The combination of orlistat, lonidamine and 6‑diazo‑5‑oxo‑L‑norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells

a U251 were treated with l-asparaginase and/or... | Download Scientific  Diagram
a U251 were treated with l-asparaginase and/or... | Download Scientific Diagram

6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica
6-Diazo-5-oxo-L-norleucine - LabNet Biotecnica

6-Diazo-5-oxo-L-norleucine (CAS 157-03-9) | Glentham Life Sciences
6-Diazo-5-oxo-L-norleucine (CAS 157-03-9) | Glentham Life Sciences

Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by  metalloporphyrins (Fe,Ru) - ScienceDirect
Chemical reactivity of 6-diazo-5-oxo-l-norleucine (DON) catalyzed by metalloporphyrins (Fe,Ru) - ScienceDirect

FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine
FD49029 | 157-03-9 | 6-Diazo-5-oxo-L-norleucine

WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine  (don) and other glutamine antagonists - Google Patents
WO2016112386A1 - Methods for bioanalysis of 6-diazo-5-oxo-l-norleucine (don) and other glutamine antagonists - Google Patents